Appendix: Technical addendum to NZMA submission on HQSC Atlas of Healthcare Variation – Opioid Domain – prepared by Dr Scott Metcalfe Comments on HQSC DHB opioid maps http: www.hqsc.govt.nz our-programmes healthqual - Metcalfe - Document - PDFSEARCH.IO

First Page		Document Content
Date: 2014-12-14 17:17:35 Euphoriants Morphinans Ethers Phenols District Health Board Morphine Oxycodone Buprenorphine Auckland Region Chemistry Organic chemistry Alcohols		Appendix: Technical addendum to NZMA submission on HQSC Atlas of Healthcare Variation – Opioid Domain – prepared by Dr Scott Metcalfe Comments on HQSC DHB opioid maps http://www.hqsc.govt.nz/our-programmes/healthqual Add to Reading List Source URL: www.nzma.org.nz Download Document from Source Website File Size: 707,74 KB Share Document on Facebook

	CLIENT BULLETIN Measuring Buprenorphine and Norbuprenorphine in Urine Buprenorphine is used as a replacement therapy in the treatment of opioid dependence and as an analgesic. This medication also has the potential for DocID: 1vgU3 - View Document
	MEDTOX® BUPRENORPHINE MEDTOX® Buprenorphine is a rapid qualitative screening test for buprenorphine and its metabolites in human urine. 1. INTENDED USE The MEDTOX Buprenorphine Test uses immunochromatographic test stri DocID: 1v9Pg - View Document
	SUBOXONE® (buprenorphine and naloxone) Sublingual Film (CIII) Talking with your doctor Opioid dependence can be treated. Talking with your healthcare team keeps them aware of your situation so they may adjust your trea DocID: 1uBp8 - View Document
	Authorization Expanded to Qualified Certified Nurse Practitioners for the Prescribing of Buprenorphine to Treat Opioid Addiction The Comprehensive Addiction and Recovery Act (CARA) was signed into law on July 22, 2016. O DocID: 1tRGm - View Document
	ATION ASSISTED TREATMENT• BUPRENORPHINE• NALTREXONE• MEDICATION ASSISTED TREATMENT• BUPRENORPHINE• NALTREXONE• MED SISTED TREATMENT• BUPRENORPHINE• NALTREXONE• MEDICATION ASSISTED TREATMENT• BUPRENOR DocID: 1tG05 - View Document